Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 7,441 $ 106,280,950 $ (104,853,710) $ 1,434,681
Balance, shares at Dec. 31, 2018 7,441,053      
Stock-based compensation expense 394,692 394,692
Equity units issued for Cash $ 379 1,724,621 1,725,000
Equity units issued for Cash, shares 379,960      
Shares relinquished $ (75) (394,335) (394,410)
Shares relinquished, shares (75,848)      
Net loss (2,686,065) (2,686,065)
Balance at Mar. 31, 2019 $ 7,745 108,005,928 (107,539,775) 473,898
Balance, shares at Mar. 31, 2019 7,745,165      
Balance at Dec. 31, 2019 $ 14,457 235,522,746 (119,858,909) 115,678,294
Balance, shares at Dec. 31, 2019 14,457,013      
Stock-based compensation expense   5,039,362 5,039,362
Warrants exercised for cash $ 447 3,041,726 3,042,173
Warrants exercised for cash. shares 447,107      
Cashless warrant exercise $ 34 (34)
Cashless warrant exercise, shares 34,114      
Options exercised $ 3 73,017 73,020
Options exercised, shares 2,434      
Net loss (10,673,316) (10,673,316)
Balance at Mar. 31, 2020 $ 14,941 $ 243,676,817 $ (130,532,225) $ 113,159,533
Balance, shares at Mar. 31, 2020 14,940,668